These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 19641890)
1. Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-kappaB-inducing kinase-specific siRNA using liver-targeting liposomes. Cho HA; Park IS; Kim TW; Oh YK; Yang KS; Kim JS Arch Pharm Res; 2009 Jul; 32(7):1077-86. PubMed ID: 19641890 [TBL] [Abstract][Full Text] [Related]
2. Biodistribution and improved anticancer effect of NIK-siRNA in combination with 5-FU for hepatocellular carcinoma. Kang SS; Cho HA; Kim JS Arch Pharm Res; 2011 Jan; 34(1):79-86. PubMed ID: 21468918 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell. Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933 [TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma inhibits hepatitis B virus-induced NF-kappaB activation through nuclear localization of NF-kappaB-inducing kinase. Park SG; Ryu HM; Lim SO; Kim YI; Hwang SB; Jung G Gastroenterology; 2005 Jun; 128(7):2042-53. PubMed ID: 15940636 [TBL] [Abstract][Full Text] [Related]
6. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference]. Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect. Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291 [TBL] [Abstract][Full Text] [Related]
8. [Small interfering RNA-mediated nuclear factor-kappaB P65 suppression induces apoptosis of hepatic carcinoma SMMC-7721 cells]. Huang C; Yao JY; Li ZF; Liu LY; Ni L; Song TS Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1841-4. PubMed ID: 18158998 [TBL] [Abstract][Full Text] [Related]
9. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells]. Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2]. Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759 [TBL] [Abstract][Full Text] [Related]
11. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth. Jin T; Fu J; Feng XJ; Wang SM; Huang X; Zhu MH; Zhang SH Cell Biol Int; 2013 Sep; 37(9):929-39. PubMed ID: 23589395 [TBL] [Abstract][Full Text] [Related]
12. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996 [TBL] [Abstract][Full Text] [Related]
13. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017 [TBL] [Abstract][Full Text] [Related]
14. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108 [TBL] [Abstract][Full Text] [Related]
15. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus. Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791 [TBL] [Abstract][Full Text] [Related]
16. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference]. Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086 [TBL] [Abstract][Full Text] [Related]
17. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro]. Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881 [TBL] [Abstract][Full Text] [Related]
18. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference. Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells. Zhang F; Wang Q; Ye L; Feng Y; Zhang X J Med Virol; 2010 May; 82(6):920-8. PubMed ID: 20419804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]